The Prometheus League
Breaking News and Updates
- Abolition Of Work
- Ai
- Alt-right
- Alternative Medicine
- Antifa
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Ascension
- Astronomy
- Atheism
- Atheist
- Atlas Shrugged
- Automation
- Ayn Rand
- Bahamas
- Bankruptcy
- Basic Income Guarantee
- Big Tech
- Bitcoin
- Black Lives Matter
- Blackjack
- Boca Chica Texas
- Brexit
- Caribbean
- Casino
- Casino Affiliate
- Cbd Oil
- Censorship
- Cf
- Chess Engines
- Childfree
- Cloning
- Cloud Computing
- Conscious Evolution
- Corona Virus
- Cosmic Heaven
- Covid-19
- Cryonics
- Cryptocurrency
- Cyberpunk
- Darwinism
- Democrat
- Designer Babies
- DNA
- Donald Trump
- Eczema
- Elon Musk
- Entheogens
- Ethical Egoism
- Eugenic Concepts
- Eugenics
- Euthanasia
- Evolution
- Extropian
- Extropianism
- Extropy
- Fake News
- Federalism
- Federalist
- Fifth Amendment
- Fifth Amendment
- Financial Independence
- First Amendment
- Fiscal Freedom
- Food Supplements
- Fourth Amendment
- Fourth Amendment
- Free Speech
- Freedom
- Freedom of Speech
- Futurism
- Futurist
- Gambling
- Gene Medicine
- Genetic Engineering
- Genome
- Germ Warfare
- Golden Rule
- Government Oppression
- Hedonism
- High Seas
- History
- Hubble Telescope
- Human Genetic Engineering
- Human Genetics
- Human Immortality
- Human Longevity
- Illuminati
- Immortality
- Immortality Medicine
- Intentional Communities
- Jacinda Ardern
- Jitsi
- Jordan Peterson
- Las Vegas
- Liberal
- Libertarian
- Libertarianism
- Liberty
- Life Extension
- Macau
- Marie Byrd Land
- Mars
- Mars Colonization
- Mars Colony
- Memetics
- Micronations
- Mind Uploading
- Minerva Reefs
- Modern Satanism
- Moon Colonization
- Nanotech
- National Vanguard
- NATO
- Neo-eugenics
- Neurohacking
- Neurotechnology
- New Utopia
- New Zealand
- Nihilism
- Nootropics
- NSA
- Oceania
- Offshore
- Olympics
- Online Casino
- Online Gambling
- Pantheism
- Personal Empowerment
- Poker
- Political Correctness
- Politically Incorrect
- Polygamy
- Populism
- Post Human
- Post Humanism
- Posthuman
- Posthumanism
- Private Islands
- Progress
- Proud Boys
- Psoriasis
- Psychedelics
- Putin
- Quantum Computing
- Quantum Physics
- Rationalism
- Republican
- Resource Based Economy
- Robotics
- Rockall
- Ron Paul
- Roulette
- Russia
- Sealand
- Seasteading
- Second Amendment
- Second Amendment
- Seychelles
- Singularitarianism
- Singularity
- Socio-economic Collapse
- Space Exploration
- Space Station
- Space Travel
- Spacex
- Sports Betting
- Sportsbook
- Superintelligence
- Survivalism
- Talmud
- Technology
- Teilhard De Charden
- Terraforming Mars
- The Singularity
- Tms
- Tor Browser
- Trance
- Transhuman
- Transhuman News
- Transhumanism
- Transhumanist
- Transtopian
- Transtopianism
- Ukraine
- Uncategorized
- Vaping
- Victimless Crimes
- Virtual Reality
- Wage Slavery
- War On Drugs
- Waveland
- Ww3
- Yahoo
- Zeitgeist Movement
-
Prometheism
-
Forbidden Fruit
-
The Evolutionary Perspective
Category Archives: Transhuman News
My Life with Plaque Psoriasis and How I’m taking Control – The Killeen Daily Herald
Posted: February 7, 2017 at 7:45 am
(BPT) - Whitney was only 19 years old, home from college freshman year, when her mother noticed spots on her arms and elbows. As any parent would be, Whitneys mother was concerned and suggested her daughter see a dermatologist. That visit revealed her diagnosis of moderate-to-severe plaque psoriasis. Little did Whitney know, this would be a lifelong battle that would impact all aspects of her life.
Plaque psoriasis is a chronic autoimmune skin disease that speeds up the growth cycle of skin cells, causing patches of thick red skin and silvery scales affecting approximately 6 million Americans.1
When I was younger and my psoriasis was flaring, it was very embarrassing and shameful, Whitney said. People didnt understand that I was not contagious. I can remember being turned away by hair stylists who didnt want to cut my hair and being refused a pedicure. My friends and boyfriends didnt understand what was going on with me and I could feel them pulling away at times.
After talking with her doctor about her symptoms, she prescribed a biologic treatment called STELARA (ustekinumab).
I went through some very challenging times with my psoriasis symptoms. Starting treatment with STELARA helped me to take control of my disease and start to create new memories with my family and friends, said Whitney. With clearer skin, I was able to walk down the aisle in a strapless wedding dress, and it was amazing!
Eventually, Whitney would also be diagnosed with psoriatic arthritis, an inflammatory arthritis causing joint pain, stiffness and swelling that affects approximately 30 percent of people with psoriasis.2 STELARA (ustekinumab) also is approved to treat psoriatic arthritis and, over time, Whitneys joint pain and swelling have diminished significantly.
Visit http://www.STELARAINFO.com to learn more about STELARA
WHAT IS STELARA?
STELARA is a prescription medicine approved to treat adults 18 years and older with moderate or severe plaque psoriasis that involves large areas or many areas of their body, who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).
STELARA is a prescription medicine approved to treat adults 18 years and older with active psoriatic arthritis, either alone or with methotrexate.
STELARA (ustekinumab) works by targeting an underlying cause of plaque psoriasis and psoriatic arthritis an overactive immune system. It blocks two proteins called IL-12 and IL-23 that may play a role in plaque psoriasis and psoriatic arthritis.
IMPORTANT SAFETY INFORMATION
STELARA (ustekinumab) is a prescription medicine that affects your immune system. STELARA can increase your chance of having serious side effects including:
Serious Infections
STELARA may lower your ability to fight infections and may increase your risk of infections. While taking STELARA, some people have serious infections, which may require hospitalization, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses.
Your doctor should check you for TB before starting STELARA and watch you closely for signs and symptoms of TB during treatment with STELARA.
If your doctor feels that you are at risk for TB, you may be treated for TB before and during treatment with STELARA.
You should not start taking STELARA if you have any kind of infection unless your doctor says it is okay.
Before starting STELARA, tell your doctor if you:
think you have an infection or have symptoms of an infection such as:
After starting STELARA, call your doctor right away if you have any symptoms of an infection (see above).
STELARA can make you more likely to get infections or make an infection that you have worse. People who have a genetic problem where the body does not make any of the proteins interleukin 12 (IL-12) and interleukin 23 (IL-23) are at a higher risk for certain serious infections that can spread throughout the body and cause death. People who take STELARA may also be more likely to get these infections.
Cancers
STELARA may decrease the activity of your immune system and increase your risk for certain types of cancer. Tell your doctor if you have ever had any type of cancer. Some people who had risk factors for skin cancer developed certain types of skin cancers while receiving STELARA. Tell your doctor if you have any new skin growths.
Reversible posterior leukoencephalopathy syndrome (RPLS)
RPLS is a rare condition that affects the brain and can cause death. The cause of RPLS is not known. If RPLS is found early and treated, most people recover. Tell your doctor right away if you have any new or worsening medical problems including: headache, seizures, confusion, and vision problems.
Serious Allergic Reactions
Serious allergic reactions can occur. Stop using STELARA and get medical help right away if you have any symptoms such as: feeling faint, swelling of your face, eyelids, tongue, or throat, chest tightness, or skin rash.
Before receiving STELARA, tell your doctor if you:
have any of the conditions or symptoms listed above for serious infections, cancers, or RPLS.
ever had an allergic reaction to STELARA or any of its ingredients. Ask your doctor if you are not sure.
are allergic to latex. The needle cover on the prefilled syringe contains latex.
have recently received or are scheduled to receive an immunization (vaccine). People who take STELARA should not receive live vaccines. Tell your doctor if anyone in your house needs a vaccine. The viruses used in some types of vaccines can spread to people with a weakened immune system, and can cause serious problems. You should not receive the BCG vaccine during the one year before taking STELARA or one year after you stop taking STELARA.
have any new or changing lesions within psoriasis areas or on normal skin.
are receiving or have received allergy shots, especially for serious allergic reactions.
receive or have received phototherapy for your psoriasis.
have any other medical conditions.
are pregnant or plan to become pregnant. It is not known if STELARA will harm your unborn baby. You and your doctor should decide if you will take STELARA.
are breast-feeding or plan to breast-feed. It is thought that STELARA passes into your breast milk. Talk to your doctor about the best way to feed your baby if you take STELARA.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.
When prescribed STELARA:
Use STELARA exactly as prescribed by your doctor.
If your doctor decides that you or a caregiver may give your injections of STELARA at home, you should receive training on the right way to prepare and inject STELARA. Do not try to inject STELARA yourself until you or your caregiver has been shown how to inject STELARA by your doctor or nurse.
Common side effects of STELARA include: upper respiratory infections, headache, and tiredness in psoriasis patients; joint pain and nausea in psoriatic arthritis patients; and upper respiratory infections, redness at the injection site, vaginal yeast infections, itching, urinary tract infections, and vomiting in Crohns disease patients. These are not all of the possible side effects with STELARA. Tell your doctor about any side effect that you experience. Ask your doctor or pharmacist for more information.
Please read the full Prescribing Information and Medication Guide for STELARA and discuss any questions you have with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.
061408-161010
References
1. About the National Psoriasis Foundation. (n.d.) https://www.psoriasis.org/about-us. Accessed July 24, 2016.
2. National Psoriasis Foundation. About Psoriatic Arthritis. https://www.psoriasis.org/psoriatic-arthritis. Accessed November 3, 2016.
(c) Janssen Biotech, Inc. 2016 11/16 057315-160728
Originally posted here:
My Life with Plaque Psoriasis and How I'm taking Control - The Killeen Daily Herald
Posted in Psoriasis
Comments Off on My Life with Plaque Psoriasis and How I’m taking Control – The Killeen Daily Herald
My Life with Plaque Psoriasis and How I’m taking Control – Bloomer … – Bloomer Advance (subscription)
Posted: at 7:45 am
(BPT) - Whitney was only 19 years old, home from college freshman year, when her mother noticed spots on her arms and elbows. As any parent would be, Whitneys mother was concerned and suggested her daughter see a dermatologist. That visit revealed her diagnosis of moderate-to-severe plaque psoriasis. Little did Whitney know, this would be a lifelong battle that would impact all aspects of her life.
Plaque psoriasis is a chronic autoimmune skin disease that speeds up the growth cycle of skin cells, causing patches of thick red skin and silvery scales affecting approximately 6 million Americans.1
When I was younger and my psoriasis was flaring, it was very embarrassing and shameful, Whitney said. People didnt understand that I was not contagious. I can remember being turned away by hair stylists who didnt want to cut my hair and being refused a pedicure. My friends and boyfriends didnt understand what was going on with me and I could feel them pulling away at times.
After talking with her doctor about her symptoms, she prescribed a biologic treatment called STELARA (ustekinumab).
I went through some very challenging times with my psoriasis symptoms. Starting treatment with STELARA helped me to take control of my disease and start to create new memories with my family and friends, said Whitney. With clearer skin, I was able to walk down the aisle in a strapless wedding dress, and it was amazing!
Eventually, Whitney would also be diagnosed with psoriatic arthritis, an inflammatory arthritis causing joint pain, stiffness and swelling that affects approximately 30 percent of people with psoriasis.2 STELARA (ustekinumab) also is approved to treat psoriatic arthritis and, over time, Whitneys joint pain and swelling have diminished significantly.
Visit http://www.STELARAINFO.com to learn more about STELARA
WHAT IS STELARA?
STELARA is a prescription medicine approved to treat adults 18 years and older with moderate or severe plaque psoriasis that involves large areas or many areas of their body, who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).
STELARA is a prescription medicine approved to treat adults 18 years and older with active psoriatic arthritis, either alone or with methotrexate.
STELARA (ustekinumab) works by targeting an underlying cause of plaque psoriasis and psoriatic arthritis an overactive immune system. It blocks two proteins called IL-12 and IL-23 that may play a role in plaque psoriasis and psoriatic arthritis.
IMPORTANT SAFETY INFORMATION
STELARA (ustekinumab) is a prescription medicine that affects your immune system. STELARA can increase your chance of having serious side effects including:
Serious Infections
STELARA may lower your ability to fight infections and may increase your risk of infections. While taking STELARA, some people have serious infections, which may require hospitalization, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses.
Your doctor should check you for TB before starting STELARA and watch you closely for signs and symptoms of TB during treatment with STELARA.
If your doctor feels that you are at risk for TB, you may be treated for TB before and during treatment with STELARA.
You should not start taking STELARA if you have any kind of infection unless your doctor says it is okay.
Before starting STELARA, tell your doctor if you:
think you have an infection or have symptoms of an infection such as:
After starting STELARA, call your doctor right away if you have any symptoms of an infection (see above).
STELARA can make you more likely to get infections or make an infection that you have worse. People who have a genetic problem where the body does not make any of the proteins interleukin 12 (IL-12) and interleukin 23 (IL-23) are at a higher risk for certain serious infections that can spread throughout the body and cause death. People who take STELARA may also be more likely to get these infections.
Cancers
STELARA may decrease the activity of your immune system and increase your risk for certain types of cancer. Tell your doctor if you have ever had any type of cancer. Some people who had risk factors for skin cancer developed certain types of skin cancers while receiving STELARA. Tell your doctor if you have any new skin growths.
Reversible posterior leukoencephalopathy syndrome (RPLS)
RPLS is a rare condition that affects the brain and can cause death. The cause of RPLS is not known. If RPLS is found early and treated, most people recover. Tell your doctor right away if you have any new or worsening medical problems including: headache, seizures, confusion, and vision problems.
Serious Allergic Reactions
Serious allergic reactions can occur. Stop using STELARA and get medical help right away if you have any symptoms such as: feeling faint, swelling of your face, eyelids, tongue, or throat, chest tightness, or skin rash.
Before receiving STELARA, tell your doctor if you:
have any of the conditions or symptoms listed above for serious infections, cancers, or RPLS.
ever had an allergic reaction to STELARA or any of its ingredients. Ask your doctor if you are not sure.
are allergic to latex. The needle cover on the prefilled syringe contains latex.
have recently received or are scheduled to receive an immunization (vaccine). People who take STELARA should not receive live vaccines. Tell your doctor if anyone in your house needs a vaccine. The viruses used in some types of vaccines can spread to people with a weakened immune system, and can cause serious problems. You should not receive the BCG vaccine during the one year before taking STELARA or one year after you stop taking STELARA.
have any new or changing lesions within psoriasis areas or on normal skin.
are receiving or have received allergy shots, especially for serious allergic reactions.
receive or have received phototherapy for your psoriasis.
have any other medical conditions.
are pregnant or plan to become pregnant. It is not known if STELARA will harm your unborn baby. You and your doctor should decide if you will take STELARA.
are breast-feeding or plan to breast-feed. It is thought that STELARA passes into your breast milk. Talk to your doctor about the best way to feed your baby if you take STELARA.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.
When prescribed STELARA:
Use STELARA exactly as prescribed by your doctor.
If your doctor decides that you or a caregiver may give your injections of STELARA at home, you should receive training on the right way to prepare and inject STELARA. Do not try to inject STELARA yourself until you or your caregiver has been shown how to inject STELARA by your doctor or nurse.
Common side effects of STELARA include: upper respiratory infections, headache, and tiredness in psoriasis patients; joint pain and nausea in psoriatic arthritis patients; and upper respiratory infections, redness at the injection site, vaginal yeast infections, itching, urinary tract infections, and vomiting in Crohns disease patients. These are not all of the possible side effects with STELARA. Tell your doctor about any side effect that you experience. Ask your doctor or pharmacist for more information.
Please read the full Prescribing Information and Medication Guide for STELARA and discuss any questions you have with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.
061408-161010
References
1. About the National Psoriasis Foundation. (n.d.) https://www.psoriasis.org/about-us. Accessed July 24, 2016.
2. National Psoriasis Foundation. About Psoriatic Arthritis. https://www.psoriasis.org/psoriatic-arthritis. Accessed November 3, 2016.
(c) Janssen Biotech, Inc. 2016 11/16 057315-160728
See the original post:
My Life with Plaque Psoriasis and How I'm taking Control - Bloomer ... - Bloomer Advance (subscription)
Posted in Psoriasis
Comments Off on My Life with Plaque Psoriasis and How I’m taking Control – Bloomer … – Bloomer Advance (subscription)
Local effects of adipose tissue in psoriasis and psoriatic arthritis – Dove Medical Press
Posted: at 7:45 am
Back to Browse Journals Psoriasis: Targets and Therapy Volume 7
Ilja L Kruglikov,1 Uwe Wollina2
1Scientific Department, Wellcomet GmbH, Karlsruhe, 2Department of Dermatology and Allergology, Hospital Dresden-Friedrichstadt Academic Teaching Hospital of the Technical University of Dresden, Dresden, Germany
Abstract: The structure and physiological state of the local white adipose tissue (WAT) located underneath the lesional psoriatic skin and inside of the joints affected by psoriatic arthritis play an important role in the pathophysiology of these diseases. WAT pads associated with inflammatory sites in psoriasis and psoriatic arthritis are, correspondingly, dermal WAT and articular adipose tissue; these pads demonstrate inflammatory phenotypes in both diseases. Such local WAT inflammation could be the primary effect in the pathophysiology of psoriasis leading to the modification of the local expression of adipokines, a change in the structure of the basement membrane and the release of keratinocytes with consequent epidermal hyperproliferation during psoriasis. Similar articular adipose tissue inflammation can lead to the induction of structural modifications and synovial inflammation in the joints of patients with psoriatic arthritis.
Keywords: psoriasis, psoriatic arthritis, pathophysiology, adipose tissue, dermal adipocytes, articular adipose tissue
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
The rest is here:
Local effects of adipose tissue in psoriasis and psoriatic arthritis - Dove Medical Press
Posted in Psoriasis
Comments Off on Local effects of adipose tissue in psoriasis and psoriatic arthritis – Dove Medical Press
LeAnn Rimes: Psoriasis is ‘one of my biggest insecurities’ – Today.com
Posted: at 7:45 am
share
pin
LeAnn Rimes is a country music superstar who's been making hit records since she was only 13 years old. The powerhouse vocalist reflects on growing up in the spotlight and how she's been able to embrace her insecurities and own them with confidence!
One of my biggest insecurities is my skin. I've had psoriasis since I was 2 and was 80 percent covered by the time I was 6, so I was constantly in a state of covering up everything as a kid and feeling really uncomfortable.
RELATED: LeAnn Rimes shares adorable throwback photo from her first cassette tape
I didn't realize how much it had impacted my self-confidence and just really kind of feeling like a woman.
LeAnn Rimes isn't afraid to bare her skin after managing her psoriasis.
So there's been a ton of bikini photos of me in the past several years; it's because I would go naked if I could because I'm clear and it's all good!
I think music really was what gave me confidence.
RELATED: Ashley Graham: What I tell myself in the mirror to feel confident
I think I was very disconnected from my body so that was the one way I could really connect. So I think music has been a very, very healing thing for me.
"Music ... was a place for me to be able to escape in a way but also kind of come out of my shell."
I never thought I could get to the place where I could really be grateful for every single thing that's happened in my life ... but I am now and it feels really good.
RELATED: 'Forever Country' brings singers from past and present together for epic video
As I get older, I've learned how to accept the things that bother me about myself and really start to love those things. They're what make me, me.
My advice to others is to own it. Own who you are, because it feels really good when you do.
As told to TODAY's Jordan Muto.
Originally posted here:
LeAnn Rimes: Psoriasis is 'one of my biggest insecurities' - Today.com
Posted in Psoriasis
Comments Off on LeAnn Rimes: Psoriasis is ‘one of my biggest insecurities’ – Today.com
Severe newborn jaundice could be preventable, mouse study shows – Science Daily
Posted: at 7:44 am
Severe newborn jaundice could be preventable, mouse study shows Science Daily To better understand UGT1A1's role in human newborns, Tukey's collaborator and senior author Shujuan Chen, PhD, assistant professor of pharmacology at UC San Diego School of Medicine, replaced the native UGT1A1 gene in mice with the human ... |
Read more from the original source:
Severe newborn jaundice could be preventable, mouse study shows - Science Daily
Posted in Gene Medicine
Comments Off on Severe newborn jaundice could be preventable, mouse study shows – Science Daily
Gene therapy allows deaf mice to hear: study – Yahoo News
Posted: at 7:44 am
Gene therapy delivered by a benign virus enabled deaf lab mice to hear for the first time, researchers said Monday, offering hope for people with genetic hearing impairments.
The breakthrough could pave the way for gene-based treatments, they reported in two studies, published in Nature Biotechnology.
"With more than 100 genes already known to cause deafness in humans, there are many patients who may eventually benefit from this technology," said Konstantina Stankovic, a professor at Harvard Medical School.
Genetic hearing disorders affect some 125 million people worldwide, according to the World Health Organization.
An expert not involved in the research welcomed the findings as "very encouraging", but cautioned the technique has yet to be proven safe, and that human trials are likely years away.
In the first study, Stankovic and colleagues used a harmless virus to transport -- deep into the mouse ear -- a gene that can fix a specific form of hereditary deafness.
Previous attempts had failed, but this time the viral package was delivered to the right address: the so-called outer hair cells that "tune" the inner ear to sound waves.
"Outer hair cells amplify sound, allowing inner hair cells to send a stronger signal to the brain," explained Gwenaelle Geleoc, a researcher at the F.M. Kirby Neurobiology Center at Boston Children's Hospital.
The technique bestowed hearing and balance "to a level that's never been achieved before," she said in a statement.
"Now you can whisper, and the mice can hear you."
In the second study, a team led by Geleoc used the same viral courier to treat mice with a mutated gene responsible for Usher syndrome, a rare childhood genetic disease that causes deafness, loss of balance, and in some cases blindness.
The virus carried a normal version of the same gene to damaged ear hair cells soon after the mice were born.
- Narrow time window -
The results far exceeded anything to date: 19 of 25 treated mice heard sounds quieter than 80 decibels. Normal human conversation is about 70 decibels.
A few of the mice could hear sounds as soft as 25 to 30 decibels -- roughly equivalent to whispering.
According to Margaret Kenna, a specialist in genetic hearing loss at Boston Children's Hospital not involved in the studies, "cochlear implants are great, but your own hearing is better."
Electronic implants work by bypassing damaged hair cells in the ear to send sound signals directly to the brain.
"Anything that could stabilise or improve native hearing at an early age would give a huge boost to a child's ability to learn and use spoken language," she said.
The need for early intervention, however, could be a problem in itself, other experts pointed out.
In humans, such an intervention would ideally have to happen before a child is born, said Jonathan Ashmore, a professor at University College London's Ear Institute.
Alan Boyd, president of Britain's Faculty of Pharmaceutical Medicine hailed "a very encouraging result".
"But it is only a mouse model," he cautioned, noting that it is still unknown how the human immune system might react.
Any gene deafness treatment is "at least three years away, if not more," Boyd conjectured.
Follow this link:
Gene therapy allows deaf mice to hear: study - Yahoo News
Posted in Gene Medicine
Comments Off on Gene therapy allows deaf mice to hear: study – Yahoo News
A US First: Gene Edited Off-the-Shelf CAR T-Cell Product Candidate – Pharmaceutical Processing
Posted: at 7:44 am
FDA grants Cellectis IND approval to proceed with the clinical development of UCART123, the first gene edited off-the-shelf CAR T-Cell product candidate developed in the U.S.
Cellectis, a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells (UCART), has received an Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) to conduct Phase 1 clinical trials with UCART123, the companys most advanced, wholly owned Talengene-edited product candidate, in patients with acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neoplasm (BPDCN).
This marks the first allogeneic, off-the-shelf gene-edited CAR T-cell product candidate that the FDA has approved for clinical trials. Cellectis intends to initiate Phase 1 trials in the first half of 2017.
UCART123 is a gene-edited T-cell investigational drug that targets CD123, an antigen expressed at the surface of leukemic cells in AML, tumoral cells in BPDCN. The clinical research for AML will be led, at Weill Cornell, by principal investigator Dr. Gail J. Roboz, Director of the Clinical and Translational Leukemia Programs and Professor of Medicine. The UCART123 clinical program for BPDCN will be led, at the MD Anderson Cancer Center, by Dr. Naveen Pemmaraju, M.D., assistant professor, and Professor Hagop Kantarjian, M.D., department chair, Department of Leukemia, Division of Cancer Medicine.
AML is a devastating clonal hematopoietic stem cell neoplasm that is characterized by uncontrolled proliferation and accumulation of leukemic blasts in bone marrow, peripheral blood and, occasionally, in other tissues. These cells disrupt normal hematopoiesis and rapidly cause bone marrow failure and death. In the U.S. alone, there are an estimated 19,950 new AML cases per year, with 10,430 estimated deaths per year.
BPDCN is a very rare and aggressive hematological malignancy that is derived from plasmacytoid dendritic cell precursors. BPDCN is a disease of bone marrow and blood cells but also often affects skin and lymph nodes.
The FDAs approval of Cellectis UCART123 the first off-the-shelf CAR T-cell product candidate to enter clinical trials in the U.S. is a major milestone not only for the company but also for the medical community, global biotech and pharmaceutical industries at large, said Dr. Loan Hoang-Sayag, Cellectis chief medical officer. Cellectis allogeneic UCART products have the potential to create an important shift with regard to availability, and cost-effectiveness, to make these therapies widely accessible to patient population across the world.
After the National Institutes of Health's Recombinant DNA Advisory Committee (RAC)s unanimous approval of two Phase 1 study protocols for Cellectis UCART123 in December 2016, the FDAs approval of Cellectis IND is a new major regulatory milestone achieved, for having UCART123 proceed into clinical development and reaching cancer patients in need, added Stephan Reynier, chief regulatory and compliance officer, Cellectis.
Information about ongoing clinical trials are publically available on dedicated websites such as: http://www.clinicaltrials.govin the U.S. http://www.clinicaltrialsregister.euin Europe.
(Source: Business Wire)
Continued here:
A US First: Gene Edited Off-the-Shelf CAR T-Cell Product Candidate - Pharmaceutical Processing
Posted in Gene Medicine
Comments Off on A US First: Gene Edited Off-the-Shelf CAR T-Cell Product Candidate – Pharmaceutical Processing
Lawrence Modisett: Need for political correctness still holds true – The Providence Journal
Posted: at 7:44 am
I am writing in response to Thomas Dentons Feb. 2 letter, Politically incorrect crowd doesnt grasp the new rules. Mr. Denton suggests that outside of the Northeast and California, political correctness has taken on a new meaning. He concludes by asking, in a rather mocking tone, How do you like being politically correct now?
Here is my answer. The phrase politically correct may invite ridicule, but the intent behind it should never be a subject for mockery, particularly in our country. Simply stated, the intent is to encourage respect for the feelings of others. It means trying to avoid words and actions that imply that someone who is different in some way is therefore less valued as a human being. Put another way, it means following what Christians refer to as the Golden Rule: Do unto others as you would have others do unto you. This principle has its counterpart in every major religion.
Contrary to what Mr. Denton implies, I believe the majority of Americans still value this rule, including the majority of those who voted for Mr. Trump.
In todays turbulent political environment, it is more critical than ever to hold true to this sacred principle and defend it whenever it comes under attack.
Lawrence Modisett
Portsmouth
More:
Lawrence Modisett: Need for political correctness still holds true - The Providence Journal
Posted in Politically Incorrect
Comments Off on Lawrence Modisett: Need for political correctness still holds true – The Providence Journal
Documents About Financial Censorship Under Operation Choke Point Show Concern from Congress, Provide Few … – EFF
Posted: at 7:43 am
EFF recently received dozens of pages of documents in response to a FOIA request we submitted about Operation Choke Point, a Department of Justice project to pressure banks and financial institutions into cutting off service to certain businesses. Unfortunately, the response from the Department of Justice leaves many questions unanswered.
EFF has been tracking instances of financial censorship for years to identify how online speech is indirectly silenced or intimidated by shuttering bank accounts, donation platforms, and other financial institutions. The Wall Street Journal wrote about the Justice Departments controversial and secretive campaign against financial institutions in 2013, and one Justice Department official quoted in the article stated:
"We are changing the structures within the financial system that allow all kinds of fraudulent merchants to operate," with the intent of "choking them off from the very air they need to survive."
While Operation Choke Point was purportedly aimed at shutting down fraudulent online payday loan companies, we became concerned that this campaign could also affect legal online businesses.
EFF filed FOIA requests with the Department of Justice (DOJ), the Consumer Financial Protection Bureau, and the Federal Trade Commission. The documents EFF received from the DOJ are primarily correspondence between members of Congress and the Department of Justice. In that correspondence, Congress members raised concerns about Operation Choke Point, asked questions about how it operates, and stated that this is an issue that constituents are sending letters about.
Sen. Harry Reid (D-NV) and Rep. Kenny Marchant (D-TX), for example, emailed the Department of Justice with specific questions about how the Department defines a high risk financial business.
In the correspondence we received, the DOJ overwhelmingly replied with form letters that didnt describe the criteria the Department used to decide whether a company was considered high risk, how many companies were currently labeled high risk, whether a company would ever know if it was considered high risk, or any appeal process for companies to have themselves removed from that category.
Rep. Sean Duffy (R-WI) wrote a letter to then Attorney General Eric Holder describing how two community banks in Wisconsin were bullied by regional agents of the FDIC, who told them to stop working with prominent online lenders:
These banks were informed that if they chose to ignore the FDIC's request, they would face "the highest levels of scrutiny they could imagine," and were given no explanation, details of complaints, or any evidence as to why these demands were being made.'
Duffy called these threats "outrageous" and "intimidation tactics."
Other members of Congress wrote to the Department of Justice about how Operation Choke Point was hampering opportunities for law-abiding Native American tribes and the Hispanic community.
Rep. Brad Sherman (D-CA), who cosponsored the Dodd-Frank Wall Street Reform and Consumer Protection Act and advocates for additional financial regulation, expressed deep concern about the Department of Justice stepping beyond the bounds of the law with Operation Choke Point. In his letter to Holder, he stated:
As much as I would like to see stronger regulation of consumer lenders, I've sworn to uphold the U.S. Constitution. Accordingly, I must oppose efforts to "legislate by prosecution" and legislate by "criminal investigation," even if I agree partly or completely with the ultimate substantive aim.
He also said, "[y]our department should conduct criminal investigations for the purpose of enforcing laws we havenot laws you (and I) might wish we had."
Unfortunately, the responses from the Department of Justice left more questions than answers. Vital details about Operation Choke Pointincluding what industries beyond online loans may be impacted, the exact criteria for labeling a business high risk, and the tactics used to pressure banks into participationare still unknown.
Many people believe that Americas financial institutions may need additional regulation, and some may believe that online lenders should face additional scrutiny. However, an intimidation squadron secretly pressuring banks to cut off businesses without due process is not the right way forward. As weve seen with digital booksellers, whistleblower websites, online publishers, and online personal ads, payment providers often cave to pressurewhether formal or informalto shut down or restrict accounts of those engaged in First Amendment-protected activity. In order to foster a future where digital expression can flourish, we need to ensure that necessary service providers like banks and payment processors dont turn into the weak link used to cut off unpopular speech.
But that requires transparency. We need more information about how the government is pressuring financial institutions. Unfortunately, the Department of Justices nonresponses to Congress dont get us any closer to understanding this complicated issue.
Check out the most recent documents EFF got in response to its FOIA request on Operation Choke Point. See documents EFF received earlier on this program.
Originally posted here:
Documents About Financial Censorship Under Operation Choke Point Show Concern from Congress, Provide Few ... - EFF
Posted in Censorship
Comments Off on Documents About Financial Censorship Under Operation Choke Point Show Concern from Congress, Provide Few … – EFF
Comparing Trump to Stalin, Australia’s Chief Scientist Warns Against Censorship – Common Dreams
Posted: at 7:43 am
Common Dreams | Comparing Trump to Stalin, Australia's Chief Scientist Warns Against Censorship Common Dreams American scientists are facing censorship on par with that imposed in the USSR under Josef Stalin, Australia's chief scientist Alan Finkel said during a scientific roundtable in Canberra, Australia, on Monday. "Science is literally under attack ... Australia's chief scientist: Trump's EPA changes akin to Stalin's censorship of science Australia's Top Scientist Blasts Donald Trump Over Stalin-Like Censorship Australia's chief scientist tears Trump's EPA mandate: 'It's reminiscent of the censorship exerted by political ... |
See the original post:
Comparing Trump to Stalin, Australia's Chief Scientist Warns Against Censorship - Common Dreams
Posted in Censorship
Comments Off on Comparing Trump to Stalin, Australia’s Chief Scientist Warns Against Censorship – Common Dreams